1. Home
  2. TDOC vs GHRS Comparison

TDOC vs GHRS Comparison

Compare TDOC & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$6.77

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$21.47

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
GHRS
Founded
2002
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
947.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
TDOC
GHRS
Price
$6.77
$21.47
Analyst Decision
Buy
Strong Buy
Analyst Count
18
8
Target Price
$7.56
$41.38
AVG Volume (30 Days)
5.1M
255.6K
Earning Date
04-29-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
N/A
Revenue This Year
$1.19
N/A
Revenue Next Year
$1.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$9.52
52 Week High
$9.77
$24.66

Technical Indicators

Market Signals
Indicator
TDOC
GHRS
Relative Strength Index (RSI) 64.27 61.88
Support Level $6.74 $12.29
Resistance Level $7.95 $24.66
Average True Range (ATR) 0.38 1.26
MACD 0.07 -0.02
Stochastic Oscillator 72.45 67.11

Price Performance

Historical Comparison
TDOC
GHRS

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: